STERIS plc (STE)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $25.43B
Last updated: Nov 17, 2026 at 4:20 PM ET
STERIS plc (STE) Stock Chart
STERIS (STE) has a latest price of $257.35 on Nov 17, 2026, 3.5% below its 52-week high of $266.68. Its price rose 0.1% over the past 12 months. The month-end price rose 239.9% over the 10 years through Oct 2026, a compound annual rate of 13.0%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $266.28 in Nov 2025 and its lowest $65.61 in Nov 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart STE with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for STE.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 9.0%, and over 6 months it rose 20.8%. The month-end price rose 8.2% over the 3 years through Oct 2026, a compound annual rate of 2.7%.
| Period | Change |
|---|---|
| 1 month | +15.9% |
| 3 months | +9.0% |
| 6 months | +20.8% |
| 12 months | +0.1% |
| 12 months, with dividends | +1.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +8.2% | +2.7% |
| 5 years | -2.8% | -0.6% |
| 10 years | +239.9% | +13.0% |
Price by Year
Its best calendar year was 2019, when the price rose 42.6%, and its weakest was 2022, when it fell 24.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $227.12 | -10.4% |
| 2025 | $253.52 | +23.3% |
| 2024 | $205.56 | -6.5% |
| 2023 | $219.85 | +19.0% |
| 2022 | $184.69 | -24.1% |
| 2021 | $243.41 | +28.4% |
| 2020 | $189.54 | +24.4% |
| 2019 | $152.42 | +42.6% |
| 2018 | $106.85 | +22.2% |
| 2017 | $87.47 | +29.8% |
Trading Range
The price is 14.5% above its 50-day average of $224.80 and 15.2% above its 200-day average of $223.45.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $257.35 | |
| 52-week high | $266.68 | -3.5% |
| 52-week low | $193.46 | +33.0% |
| 50-day average | $224.80 | +14.5% |
| 200-day average | $223.45 | +15.2% |
Price Risk
Over 3 years, its largest fall from a peak was 25.6%.
| Measure | Value |
|---|---|
| 1-year beta | 0.40 |
| Largest fall, 1 year | -25.6% |
| Largest fall, 3 years | -25.6% |
Valuation
STERIS traded at 25.2x earnings at the end of 2025, against a 5-year median of 25.0x and a 10-year median of 25.3x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About STE
What is STE's 1-year price change?
STERIS's price rose 0.1% over the past 12 months. With dividends included, the 12-month total return was 1.4%.
What is STE's 5-year price change?
STERIS's month-end price fell 2.8% over the 5 years through Oct 2026, a compound annual decline of 0.6%. These figures leave out dividends.
What is STE's 52-week high and low?
STERIS's 52-week high is $266.68 and its 52-week low is $193.46. Its latest price of $257.35 on Nov 17, 2026 is 3.5% below the high.
What is STE's beta?
STERIS's 1-year beta against the S&P 500 is 0.40, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 25.6%.
Is the STE chart free?
Yes. Advanced Charting for STE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
STE pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts